OGIVRI subst sèche 150 mg flac
7680674670018
CH-67467
L01FD01
07.16.1.
Reimbursement limitations:
OGIVRPERJ.01
OGIVRI en association avec le pertuzumab (PERJETA) comme traitement adjuvant du cancer du sein
Les …
1 / 3
google
Details
- Product number
- 6746701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- trastuzumabum 150 mg, histidinum, histidini hydrochloridum monohydricum, macrogolum 3350, sorbitolum 115.2 mg, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium 0.07 mg.
Articles (1)
Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
115.2 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.07 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 513.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2020
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 67467
- Drug name
- Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L01FD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 02/04/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OGIVRI subst sèche 150 mg flac
- Description (DE)
- OGIVRI Trockensub 150 mg Durchstf
- Market launch
- 02/04/2020
- Narcotic (BTM)
- No